ID: hyaluronic_acid
Aliases: HYALURONIC ACID, HA, sodium hyaluronate, hyaluronan
Type: compound
Route/form: topical/oral/injectable/device route depends heavily on formulation and indication
Status: approved_device_or_supplement_context
Evidence level: human RCT
Best data tier: human controlled/review
Support scope: human, non-human/mechanistic, review/regulatory
Source types: government_review, human_rct, preclinical
Linked sources: 3
Broad outcomes: Gut / immune / inflammation, Muscle growth / performance / recovery, Skin / wound repair
Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.
Targets / mechanism
- extracellular matrix hydration
- viscoelastic tissue filler/lubricant
- barrier and microbiome effects depend on molecular weight
Optimization domains
- skin
- joint health
- gut health
- wound healing
- aesthetics
Research basis
- Human and regulatory contexts exist for hyaluronic-acid fillers, viscosupplementation/oral skin products, and molecular-weight-specific gut-barrier research.
- The existing HMW-HA colitis entry covers a specific microbiome/barrier mechanism.
Limits, risks, and missing evidence
- Injectable fillers, oral supplements, topical products, and research polymers should not be conflated.
Risk flags
- formulation specific
- device or filler risk
- injection complications
- molecular weight matters
Linked papers, labels, and reviews
- FDA: Dermal fillers, including hyaluronic acid fillers
government_review / fda_dermal_fillers_hyaluronic_acid
Regulatory and safety context for injectable hyaluronic acid dermal fillers. - Oral hyaluronan relieves wrinkles and improves dry skin: a 12-week double-blinded placebo-controlled study
human_rct / pubmed_oral_hyaluronic_acid_skin_2021
Oral supplement context; product and molecular-weight specificity matter. - High-molecular weight hyaluronic acid protects against colitis by remodeling microbiota and restoring barrier function
preclinical / sciencedirect_hmw_ha_colitis_2026
Molecular-weight-dependent hyaluronic acid colitis model.